CDO1 and obesity due to melanocortin 4 receptor deficiency: Whereas most studies underscoring the anti-obesity effects of taurine relate to animal work,4, 5, 6 there is only a handful of studies to substantiate alleviative effects of taurine in metabolic syndromes in humans,7,8 and perhaps none so far that captures modulations in CDO1 expression and activity in humans with obesity.